Clinical Pharmacology of Clazosentan, a Selective Endothelin A Receptor Antagonist for the Prevention and Treatment of aSAH-Related Cerebral Vasospasm.
clazosentan
endothelin
pharmacodynamics
pharmacokinetics
subarachnoid hemorrhage–SAH
Journal
Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923
Informations de publication
Date de publication:
2020
2020
Historique:
received:
16
11
2020
accepted:
30
12
2020
entrez:
22
2
2021
pubmed:
23
2
2021
medline:
23
2
2021
Statut:
epublish
Résumé
Aneurysmal subarachnoid hemorrhage (aSAH) may lead to cerebral vasospasm and is associated with significant morbidity and mortality. It represents a major unmet medical need due to few treatment options with limited efficacy. The role of endothelin-1 (ET-1) and its receptor ET
Identifiants
pubmed: 33613288
doi: 10.3389/fphar.2020.628956
pii: 628956
pmc: PMC7890197
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
628956Informations de copyright
Copyright © 2021 Juif, Dingemanse and Ufer.
Déclaration de conflit d'intérêts
PJ, JD, and MU are employees of Idorsia Pharmaceuticals Ltd., the license holder of clazosentan and possess stock options/shares. The views expressed in this article are those of the authors and do not necessarily reflect those of their company.
Références
Hypertension. 2003 Jun;41(6):1253-8
pubmed: 12743011
Pharmacol Ther. 2006 Jun;110(3):386-414
pubmed: 16219361
Lancet Neurol. 2011 Jul;10(7):618-25
pubmed: 21640651
Cerebrovasc Dis. 2017;44(1-2):59-67
pubmed: 28463833
Pharmacol Rev. 2016 Apr;68(2):357-418
pubmed: 26956245
Mol Med Rep. 2018 Dec;18(6):5229-5236
pubmed: 30272323
N Engl J Med. 1983 Mar 17;308(11):619-24
pubmed: 6338383
J Clin Med. 2020 Mar 18;9(3):
pubmed: 32197449
Nat Rev Neurol. 2014 Jan;10(1):44-58
pubmed: 24323051
Eur J Clin Pharmacol. 2014 Apr;70(4):409-19
pubmed: 24458541
Cochrane Database Syst Rev. 2007 Jul 18;(3):CD000277
pubmed: 17636626
World Neurosurg. 2019 Mar;123:e235-e244
pubmed: 30496924
Stroke. 2016 Dec;47(12):2945-2951
pubmed: 27827324
J Pharmacol Exp Ther. 1997 Dec;283(3):1110-8
pubmed: 9399983
Biochem Biophys Res Commun. 1994 Mar 30;199(3):1461-5
pubmed: 8147891
Am J Pathol. 2000 Nov;157(5):1703-11
pubmed: 11073829
Crit Care Med. 2000 Apr;28(4):984-90
pubmed: 10809270
Glob Cardiol Sci Pract. 2014 Jun 18;2014(2):62-78
pubmed: 25405182
J Stroke Cerebrovasc Dis. 2019 Aug;28(8):2155-2158
pubmed: 31103551
Br J Neurosurg. 2011 Dec;25(6):677-83
pubmed: 21344979
Nephrol Dial Transplant. 2004 Nov;19(11):2742-6
pubmed: 15328386
AJNR Am J Neuroradiol. 2004 Jun-Jul;25(6):1067-76
pubmed: 15205150
AJNR Am J Neuroradiol. 2008 Jun;29(6):1053-60
pubmed: 18372422
Int J Clin Pharmacol Ther. 2009 Mar;47(3):169-77
pubmed: 19281726
J Stroke Cerebrovasc Dis. 2015 Jul;24(7):1453-64
pubmed: 25957908
BMJ. 1989 Mar 11;298(6674):636-42
pubmed: 2496789
World Neurosurg. 2019 Aug;128:e639-e648
pubmed: 31054336
J Neurosurg. 2005 Jul;103(1):9-17
pubmed: 16121967
Clin Sci (Lond). 2002 Aug;103 Suppl 48:318S-321S
pubmed: 12193113
J Clin Pharmacol. 2007 Nov;47(11):1374-80
pubmed: 17906281
Acta Neurochir (Wien). 2020 Sep;162(9):2251-2259
pubmed: 32601806
Expert Opin Drug Metab Toxicol. 2015 Mar;11(3):437-49
pubmed: 25604973
Neurol Res Int. 2013;2013:571328
pubmed: 23431440
Cardiovasc Drug Rev. 2002 Winter;20(1):53-66
pubmed: 12070534
Iran J Neurol. 2015 Jan 5;14(1):22-8
pubmed: 25874053
Stroke. 2012 Jun;43(6):1711-37
pubmed: 22556195
Br J Pharmacol. 2009 Oct;158(3):693-705
pubmed: 19785645
Life Sci. 2014 Nov 24;118(2):110-9
pubmed: 24780317
J Cereb Blood Flow Metab. 2000 Mar;20(3):499-504
pubmed: 10724114
Neurol Res Int. 2013;2013:506584
pubmed: 24058736
Stroke. 2017 Nov;48(11):2958-2963
pubmed: 28974630
Curr Neuropharmacol. 2020;18(1):65-82
pubmed: 31560289
World Neurosurg. 2018 Feb;110:e100-e111
pubmed: 29107164
Am J Physiol Heart Circ Physiol. 2002 Sep;283(3):H983-9
pubmed: 12181127
Neurocrit Care. 2019 Feb;30(1):88-97
pubmed: 30014184
Eur J Clin Pharmacol. 2007 Feb;63(2):151-8
pubmed: 16636870
Clin Transl Sci. 2019 Sep;12(5):440-444
pubmed: 31004470
Neurosurg Clin N Am. 2010 Apr;21(2):221-33
pubmed: 20380965
Clin Neuropharmacol. 2015 May-Jun;38(3):104-8
pubmed: 25970278
Lancet Neurol. 2009 Jul;8(7):635-42
pubmed: 19501022
AAPS J. 2020 Aug 3;22(5):103
pubmed: 32748293
Clin Exp Hypertens. 2008 Nov;30(8):744-66
pubmed: 19021025
Curr Clin Pharmacol. 2017;12(4):210-222
pubmed: 29473523
World Neurosurg. 2016 Jan;85:56-76
pubmed: 26342775
Pflugers Arch. 2001 Mar;441(6):844-9
pubmed: 11316270
BMJ. 2018 Jan 18;360:j5745
pubmed: 29348138
Neurocrit Care. 2011 Aug;15(1):19-27
pubmed: 21286855
J Neurosurg. 2008 Dec;109(6):1134-40
pubmed: 19035733
J Neurosurg. 1996 Mar;84(3):405-14
pubmed: 8609551
Clin Drug Investig. 2007;27(11):797-802
pubmed: 17914898
Stroke. 1988 Oct;19(10):1250-6
pubmed: 3176085
Clin Neurol Neurosurg. 2018 Jul;170:67-72
pubmed: 29730271
Br J Clin Pharmacol. 2011 Jan;71(1):52-60
pubmed: 21143501
Am J Pathol. 2000 Nov;157(5):1537-47
pubmed: 11073813
Adv Pharmacol. 2016;77:143-75
pubmed: 27451097
J Clin Pharmacol. 2011 Mar;51(3):413-21
pubmed: 20926750
Neurochem Res. 1999 Dec;24(12):1499-505
pubmed: 10591398
Stroke. 2008 Nov;39(11):3015-21
pubmed: 18688013
Ann Intensive Care. 2011 May 24;1(1):12
pubmed: 21906344
Stroke. 2016 Aug;47(8):1975-81
pubmed: 27444257
Stroke. 2017 Jan;48(1):145-151
pubmed: 27932607
Stroke. 2018 Mar;49(3):693-699
pubmed: 29438081
Neurosurgery. 2017 Jul 1;81(1):N3-N4
pubmed: 28873993
Stroke. 2012 Jun;43(6):1463-9
pubmed: 22403047
Neuroradiol J. 2016 Feb;29(1):72-81
pubmed: 26825134
BMC Neurol. 2012 Sep 22;12:99
pubmed: 22998483
Cell Mol Life Sci. 2011 Jan;68(2):195-203
pubmed: 20848158
Drug Metab Dispos. 2014 Sep;42(9):1466-77
pubmed: 24989889